Compare USPH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USPH | AXGN |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | United States |
| Employees | 5500 | 452 |
| Industry | Medical/Nursing Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1996 | 2013 |
| Metric | USPH | AXGN |
|---|---|---|
| Price | $82.59 | $29.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $106.50 | $36.11 |
| AVG Volume (30 Days) | 208.2K | ★ 823.7K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $780,990,000.00 | $225,208,000.00 |
| Revenue This Year | $9.20 | $17.30 |
| Revenue Next Year | $5.73 | $17.21 |
| P/E Ratio | $58.30 | ★ N/A |
| Revenue Growth | 16.33 | ★ 20.21 |
| 52 Week Low | $62.77 | $9.22 |
| 52 Week High | $93.50 | $36.00 |
| Indicator | USPH | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 35.43 |
| Support Level | $81.46 | $29.44 |
| Resistance Level | $88.69 | $34.70 |
| Average True Range (ATR) | 3.28 | 1.81 |
| MACD | -0.48 | -0.59 |
| Stochastic Oscillator | 51.74 | 11.32 |
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.